Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

[The first experience of application of standardized genotype technique of identification of HIV-tropism].

Lopatukhin AÉ, Kireev DE, Poliakov AN, Bukin EK, Kaiser R, Luebke N, Kuevda DA, Shipulin GA.

Klin Lab Diagn. 2013 Jun;(6):46-8. Russian.

PMID:
24340948
2.

HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples.

Lihana RW, Khamadi SA, Lwembe RM, Kinyua JG, Muriuki JK, Lagat NJ, Okoth FA, Makokha EP, Songok EM.

BMC Infect Dis. 2009 Dec 30;9:215. doi: 10.1186/1471-2334-9-215.

3.

Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation.

Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R, Schadendorf D, Dittmer U, Esser S; Essen HIV AlloSCT Group.

N Engl J Med. 2014 Aug 28;371(9):880-2. doi: 10.1056/NEJMc1405805. No abstract available.

4.

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.

Svicher V, D'Arrigo R, Alteri C, Andreoni M, Angarano G, Antinori A, Antonelli G, Bagnarelli P, Baldanti F, Bertoli A, Borderi M, Boeri E, Bonn I, Bruzzone B, Callegaro AP, Cammarota R, Canducci F, Ceccherini-Silberstein F, Clementi M, Monforte AD, De Luca A, Di Biagio A, Di Gianbenedetto S, Di Perri G, Di Pietro M, Fabeni L, Fadda G, Galli M, Gennari W, Ghisetti V, Giacometti A, Gori A, Leoncini F, Maggiolo F, Maserati R, Mazzotta F, Micheli V, Meini G, Monno L, Mussini C, Nozza S, Paolucci S, Parisi S, Pecorari M, Pizzi D, Quirino T, Re MC, Rizzardini G, Santangelo R, Soria A, Stazi F, Sterrantino G, Turriziani O, Viscoli C, Vullo V, Lazzarin A, Perno CF; OSCAR Study Group.

New Microbiol. 2010 Jul;33(3):195-206.

5.

Presence of CXCR4-using HIV-1 in patients with recently diagnosed infection: correlates and evidence for transmission.

Chalmet K, Dauwe K, Foquet L, Baatz F, Seguin-Devaux C, Van Der Gucht B, Vogelaers D, Vandekerckhove L, Plum J, Verhofstede C.

J Infect Dis. 2012 Jan 15;205(2):174-84. doi: 10.1093/infdis/jir714. Epub 2011 Dec 5.

6.

Genotypic inference of HIV-1 tropism using population-based sequencing of V3.

McGovern RA, Harrigan PR, Swenson LC.

J Vis Exp. 2010 Dec 27;(46). pii: 2531. doi: 10.3791/2531.

7.

Comparison of two genotypic algorithms to determine HIV-1 tropism.

Soulié C, Derache A, Aimé C, Marcelin AG, Carcelain G, Simon A, Katlama C, Calvez V.

HIV Med. 2008 Jan;9(1):1-5. doi: 10.1111/j.1468-1293.2008.00518.x.

8.

Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.

McGovern RA, Thielen A, Mo T, Dong W, Woods CK, Chapman D, Lewis M, James I, Heera J, Valdez H, Harrigan PR.

AIDS. 2010 Oct 23;24(16):2517-25. doi: 10.1097/QAD.0b013e32833e6cfb.

PMID:
20736814
9.

Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis?

Hedskog C, Mild M, Albert J.

J Infect Dis. 2012 Jan 15;205(2):163-5. doi: 10.1093/infdis/jir719. Epub 2011 Dec 5. No abstract available.

10.

Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropism.

Raymond S, Recordon-Pinson P, Saliou A, Delobel P, Nicot F, Descamps D, Marcelin AG, Flandre P, Calvez V, Masquelier B, Izopet J; ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2011 Sep;66(9):1972-5. doi: 10.1093/jac/dkr224. Epub 2011 Jun 14.

11.

Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years.

Soulie C, Lambert-Niclot S, Wirden M, Simon A, Valantin MA, Fourati S, Tubiana R, Katlama C, Calvez V, Marcelin AG.

AIDS. 2011 Feb 20;25(4):537-9. doi: 10.1097/QAD.0b013e32834345d3.

PMID:
21139487
12.

Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice.

Symons J, Vandekerckhove L, Paredes R, Verhofstede C, Bellido R, Demecheleer E, van Ham PM, van Lelyveld SF, Stam AJ, van Versendaal D, Nijhuis M, Wensing AM.

Clin Microbiol Infect. 2012 Jun;18(6):606-12. doi: 10.1111/j.1469-0691.2011.03631.x. Epub 2011 Sep 9.

13.

Update on clinical and methodological recommendations for genotypic determination of HIV tropism to guide the usage of CCR5 antagonists.

Poveda E, Paredes R, Moreno S, Alcamí J, Córdoba J, Delgado R, Gutiérrez F, Llibre JM, García Deltoro M, Hernández-Quero J, Pulido F, Iribarren JA, García F.

AIDS Rev. 2012 Jul-Sep;14(3):208-17. Review.

PMID:
22833064
14.

A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters.

Sánchez V, Masiá M, Robledano C, Padilla S, Lumbreras B, Poveda E, De Mendoza C, Soriano V, Gutiérrez F.

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):51-8. doi: 10.1097/QAI.0b013e3181fc012b.

PMID:
21068675
15.

Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.

Visseaux B, Charpentier C, Taieb A, Damond F, Bénard A, Larrouy L, Chêne G, Brun-Vézinet F, Matheron S, Descamps D; ANRS CO5 HIV-2 Cohort.

AIDS. 2013 Jan 14;27(2):292-5. doi: 10.1097/QAD.0b013e32835b8bbd.

PMID:
23095312
16.

The utility of genotypic tropism testing in clinical practice.

Wyatt H, Herman OM, Macartney M, Conibear T, Garcia-Diaz A, Booth C, McCormick A, Smith C, Johnson MA, Irish D, Webster DP.

Int J STD AIDS. 2015 Jul;26(8):593-4. doi: 10.1177/0956462414546917. Epub 2014 Aug 20.

PMID:
25147237
17.

HIV type 1 coreceptor tropism, CCR5 genotype, and integrase inhibitor resistance profiles in Vietnam: implications for the introduction of new antiretroviral regimens.

Luu QP, Dean J, Do TT, Carr MJ, Dunford L, Coughlan S, Connell J, Nguyen HT, Hall WW, Nguyen Thi LA.

AIDS Res Hum Retroviruses. 2012 Oct;28(10):1344-8. Epub 2012 Mar 9.

PMID:
22264071
18.

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses.

Raymond S, Delobel P, Mavigner M, Ferradini L, Cazabat M, Souyris C, Sandres-Sauné K, Pasquier C, Marchou B, Massip P, Izopet J.

J Acquir Immune Defic Syndr. 2010 Feb;53(2):167-75. doi: 10.1097/QAI.0b013e3181c8413b.

PMID:
19996764
19.

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.

Vandekerckhove L, Verhofstede C, Demecheleer E, De Wit S, Florence E, Fransen K, Moutschen M, Mostmans W, Kabeya K, Mackie N, Plum J, Vaira D, Van Baelen K, Vandenbroucke I, Van Eygen V, Van Marck H, Vogelaers D, Geretti AM, Stuyver LJ.

J Antimicrob Chemother. 2011 Feb;66(2):265-72. doi: 10.1093/jac/dkq458. Epub 2010 Dec 31.

20.

Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.

Soulié C, Fourati S, Lambert-Niclot S, Malet I, Wirden M, Tubiana R, Valantin MA, Katlama C, Calvez V, Marcelin AG.

J Antimicrob Chemother. 2010 Apr;65(4):749-51. doi: 10.1093/jac/dkq029. Epub 2010 Feb 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk